congenital adrenal hyperplasia due to 21-hydroxylase deficiency
%D9%81%D8%B1%D8%B7_%D8%AA%D9%86%D8%B3%D8%AC_%D8%A7%D9%84%D9%83%D8%B8%D8%B1%D9%8A%D8%A9_%D8%A7%D9%84%D8%AE%D9%84%D9%82%D9%8A_%D8%A8%D8%B3%D8%A8%D8%A8_%D9%86%D9%82%D8%B5_%D8%A5%D9%86%D8%B2%D9%8A%D9%85_21_-_%D9%87%D9%8A%D8%AF%D8%B1%D9%88%D9%83%D8%B3%D9%8A%D9%84%D9%8A%D8%B2Klassische_21-OHD_CAHCongenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency%D0%92%D1%80%D0%BE%D0%B6%D0%B4%D1%91%D0%BD%D0%BD%D0%B0%D1%8F_%D0%B3%D0%B8%D0%BF%D0%B5%D1%80%D0%BF%D0%BB%D0%B0%D0%B7%D0%B8%D1%8F_%D0%BA%D0%BE%D1%80%D1%8B_%D0%BD%D0%B0%D0%B4%D0%BF%D0%BE%D1%87%D0%B5%D1%87%D0%BD%D0%B8%D0%BA%D0%BE%D0%B2_%D0%B2%D1%81%D0%BB%D0%B5%D0%B4%D1%81%D1%82%D0%B2%D0%B8%D0%B5_%D0%BD%D0%B5%D0%B4%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%BE%D1%87%D0%BD%D0%BE%D1%81%D1%82%D0%B8_21-%D0%B3%D0%B8%D0%B4%D1%80%D0%BE%D0%BA%D1%81%D0%B8%D0%BB%D0%B0%D0%B7%D1%8BQ4127185
about
sameAs
Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiencyCardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyHeight outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Evidence from recent dataNormal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single centerBlood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyAn Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyCongenital adrenal hyperplasia due to 21-hydroxylase deficiency.The ratio of second- and fourth-digit lengths and congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses.Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPrenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPrenatal diagnosis of a heterozygote of salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency by genetic linkage analysis.Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report.Concurrence of Meningomyelocele and Salt-Wasting Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPrenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a 10 year experience.Treatment of adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a clinical practice audit.Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyRecent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is associated with a prolonged gestational age.Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A five-year retrospective study in the Children's Hospital of Damascus, Syria.Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review.Complement component 4 copy number variation and CYP21A2 genotype associations in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.A rare combination: congenital adrenal hyperplasia due to 21 hydroxylase deficiency and Turner syndrome.Rare and severe complications of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case reportMineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency.A Case of Bilateral Testicular Tumors Subsequently Diagnosed as Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
P921
Q54808422-43EFC533-CE3A-4D2E-AD55-EBDFDA376918Q54829785-4BAB6783-A1F1-4F04-92D5-ED223DF80DB0Q54837386-6972DD03-EAA5-4B6C-A7B4-E55483BB8DF7Q54837387-150BC581-E345-4E73-99DE-A14CA8C25BC8Q54845257-B8DB1D31-17B9-4EA1-B58C-2FE61FCF8144Q54845595-18393EAE-15AB-491D-89B2-FA618C700CE9Q54847430-3211CDCA-127E-4005-AAF6-B312933AF3CAQ54903293-3947D619-70BE-4776-93F3-C6C5A997C123Q54903972-917872C7-C3A7-4F77-9904-4F312A2A5859Q54907235-C30AD150-2347-4566-8098-35C745EE9DBDQ54947577-F6F27B10-17E3-49D5-BA7A-B6C9DDCE635E
P5166
Q26751005-F462B171-776B-48DA-ADC8-125985B247E9Q28299004-A14F64C7-2875-431C-AA8A-D1C0E070C6CCQ30662502-18EC6B8D-44A1-480F-8A51-397E5B91ECC1Q31032739-CE4B8F47-28F7-4C1E-B462-A54FF1CA12E9Q32087378-093F3BC1-3DDF-483F-B830-C7F11B902DB4Q33635253-DB74224F-4479-4BC3-B0F3-77DF1CE33B2DQ33651842-6A9EE8AF-566F-4E9D-A516-344CE22504DEQ33743652-04505D23-22BD-43A5-8DBC-0BE2EB336A89Q33905972-2ED46505-A12C-4B18-9CB4-A1C116AF1BA6Q34159890-71578D1F-1B13-47A1-BFFD-2947F3851801Q34235764-600506F2-425C-4886-86C1-CAA87DB9B468Q34260746-8C80B907-DDFB-471C-AF91-CA8E569E3A9FQ34272142-74772944-57D6-48F8-8043-97688673877AQ34359296-DC0F8244-4040-48D0-A65B-4BDC56273F24Q34377663-B7BA01B7-1038-4EBF-B9F5-2E14EFC1CC58Q34534232-A196BC71-690C-41E5-A6BA-2C6C9C57677CQ34566613-9B17507D-15E9-44E6-96AA-AD08EEC77C0FQ34571853-6D07E387-503C-42A9-A75F-B100FFD99709Q34649575-A820CC9E-B55A-4522-A6D2-961BCC05C39EQ34876171-D142BC5C-94D1-4B53-8F68-D8CE301E5E1FQ35036934-03BD569F-C596-4E7A-B8F7-3661C364B371Q35041404-DD3AACF3-8D1E-475E-91B7-9D1919B0523EQ35094811-F218E597-CD6A-4026-B626-26756338C688Q35179692-F593BE50-CD5F-4F99-8BD2-E43276E7F539Q35511535-2FFBC241-A164-46E9-BDFC-78B30A6DC656Q35548889-EC122D7A-DC9F-419A-9376-1A2C02951188Q35570229-B0C03966-6938-460A-8784-2EAD6BD594C1Q35605548-48A050D2-A168-436F-9565-F0A0E89F0816Q35916502-A2728949-6AC9-4784-8DC3-A4CC31A1FA88Q35932779-B37DA5A0-EC8B-4943-9DFB-6B82C6C98F9CQ36155738-9636B620-71F8-4A48-9C9B-6F72C75546EEQ36187459-DD501753-40EB-418F-8DEF-FC5C4251789EQ36269025-D99300C9-F7D7-4217-9345-5B35332902AAQ36385217-12093874-D384-4047-B010-B3DA622A5240Q36436509-152A2F99-8DE5-4593-8A05-051D2E8D015DQ36494432-EB0244B0-A21A-4EF3-9745-2B1D33C69600Q36509540-CA2B86B7-DEF1-4BD6-B2D5-5A8323836EC3Q36624244-8F794BAC-E176-4E2A-B9A0-321BE7989C07Q36644743-AB6B1E9C-5DA3-4B14-AA2E-C0F6C0EB7137Q36690851-306A27B2-92FD-44D3-8DCB-6895411FC686
P921
congenital adrenal hyperplasia due to 21-hydroxylase deficiency
name
Klassische 21-OHD CAH
@de
congenital adrenal hyperplasia due to 21-hydroxylase deficiency
@en
hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
@fr
Врождённая гиперплазия коры надпочечников вследствие недостаточности 21-гидроксилазы
@ru
فرط تنسج الكظرية الخلقي بسبب نقص إنزيم 21 - هيدروكسيليز
@ar
类固醇21-羟化酶缺乏症
@zh
类固醇21-羟化酶缺乏症
@zh-hans
類固醇21-羥化酶缺乏症
@zh-hant
type
label
Klassische 21-OHD CAH
@de
congenital adrenal hyperplasia due to 21-hydroxylase deficiency
@en
hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
@fr
Врождённая гиперплазия коры надпочечников вследствие недостаточности 21-гидроксилазы
@ru
فرط تنسج الكظرية الخلقي بسبب نقص إنزيم 21 - هيدروكسيليز
@ar
类固醇21-羟化酶缺乏症
@zh
类固醇21-羟化酶缺乏症
@zh-hans
類固醇21-羥化酶缺乏症
@zh-hant
altLabel
21-hydroxylase deficieny
@en
CYP21 deficiency
@en
adrenal gland hyperplasia 3
@en
adrenal gland hyperplasia III
@en
Врождённая гиперплазия надпочечников вследствие недостаточности 21-гидроксилазы
@ru
فرط تنسج الكظرية الخلقي بسبب نقص إنزيم ٢١ - هيدروكسيليز
@ar
prefLabel
Klassische 21-OHD CAH
@de
congenital adrenal hyperplasia due to 21-hydroxylase deficiency
@en
hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
@fr
Врождённая гиперплазия коры надпочечников вследствие недостаточности 21-гидроксилазы
@ru
فرط تنسج الكظرية الخلقي بسبب نقص إنزيم 21 - هيدروكسيليز
@ar
类固醇21-羟化酶缺乏症
@zh
类固醇21-羟化酶缺乏症
@zh-hans
類固醇21-羥化酶缺乏症
@zh-hant
P6366
P1550
P1748
P1995
P31
P4317
P492
P6366
2777029063